Metformine Evolugen (Metformin Hydrochloride)

Metformin acts primarily by activating AMP‑activated protein kinase (AMPK) in the liver, which suppresses gluconeogenesis and reduces hepatic glucose output. It also enhances insulin‑mediated glucose uptake in skeletal muscle and improves peripheral insulin sensitivity, leading to lower circulating glucose levels without increasing insulin secretion.

The exact dose of Metformine Evolugen is individualized by the prescribing healthcare professional based on factors such as the patient’s renal function, glycaemic targets, concomitant medications, and tolerability. No fixed regimen is provided here; the prescriber will set the appropriate dosage and titration schedule.

Safety data for metformin in pregnancy are limited, and its use should only be considered when the potential benefit outweighs any possible risk to the fetus. Metformin is excreted in breast‑milk in small amounts; breastfeeding mothers should discuss continuation with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Metformine Evolugen belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and offers benefits such as modest weight loss and cardiovascular risk reduction, making it a first‑line therapy for many patients.

Metformine Evolugen should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Metformine Evolugen is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are determined by the prescribing clinician based on individual therapeutic goals.

The most critical adverse event is lactic acidosis, a rare but potentially fatal condition that presents with rapid breathing, muscle pain, abdominal discomfort, and feeling of cold. Other serious concerns include severe skin reactions such as Stevens‑Johnson syndrome and marked vitamin B12 deficiency with long‑term therapy.

Metformine Evolugen is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin or any component of the formulation.